Literature DB >> 25337275

Interaction of DNA repair gene polymorphisms and aflatoxin B1 in the risk of hepatocellular carcinoma.

Jin-Guang Yao1, Xiao-Ying Huang1, Xi-Dai Long2.   

Abstract

Aflatoxin B1 (AFB1) is an important environmental carcinogen and can induce DNA damage and involve in the carcinogenesis of hepatocellular carcinoma (HCC). The deficiency of DNA repair capacity related to the polymorphisms of DNA repair genes might play a central role in the process of HCC tumorigenesis. However, the interaction of DNA repair gene polymorphisms and AFB1 in the risk of hepatocellular carcinoma has not been elucidated. In this study, we investigated whether six polymorphisms (including rs25487, rs861539, rs7003908, rs28383151, rs13181, and rs2228001) in DNA repair genes (XPC, XRCC4, XRCC1, XRCC4, XPD, XRCC7, and XRCC3) interacted with AFB1, and the gene-environmental interactive role in the risk of HCC using hospital-based case-control study (including 1486 HCC cases and 1996 controls). Genotypes of DNA repair genes were tested using TaqMan-PCR technique. Higher AFB1 exposure was observed among HCC patients versus the control group [odds ratio (OR) = 2.08 for medium AFB1 exposure level and OR = 6.52 for high AFB1 exposure level]. Increasing risk of HCC was also observed in these with the mutants of DNA repair genes (risk values were from 1.57 to 5.86). Furthermore, these risk roles would be more noticeable under the conditions of two variables, and positive interactive effects were proved in the followed multiplicative interaction analysis. These results suggested that DNA repair risk genotypes might interact with AFB1 in the risk of HCC.

Entities:  

Keywords:  Aflatoxin B1; DNA repair gene; hepatocellular carcinoma; interaction effect; polymorphism

Mesh:

Substances:

Year:  2014        PMID: 25337275      PMCID: PMC4203246     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  60 in total

1.  Conditional transformation of immunoglobulin mutation pattern from gene conversion into point mutation by controlling XRCC3 expression in the DT40 B cell line.

Authors:  Masamichi Kajita; Masaki Magari; Kagefumi Todo; Naoki Kanayama; Hitoshi Ohmori
Journal:  J Biosci Bioeng       Date:  2009-10-27       Impact factor: 2.894

2.  Association between genetic polymorphisms in the XRCC1, XRCC3, XPD, GSTM1, GSTT1, MSH2, MLH1, MSH3, and MGMT genes and radiosensitivity in breast cancer patients.

Authors:  Monica Mangoni; Simonetta Bisanzi; Francesca Carozzi; Cristina Sani; Giampaolo Biti; Lorenzo Livi; Emanuela Barletta; Adele Seniori Costantini; Giuseppe Gorini
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-08-12       Impact factor: 7.038

3.  Elevated aflatoxin exposure and increased risk of hepatocellular carcinoma.

Authors:  C J Chen; L Y Wang; S N Lu; M H Wu; S L You; Y J Zhang; L W Wang; R M Santella
Journal:  Hepatology       Date:  1996-07       Impact factor: 17.425

Review 4.  XRCC3 and XPD/ERCC2 single nucleotide polymorphisms and the risk of cancer: a HuGE review.

Authors:  Maurizio Manuguerra; Federica Saletta; Margaret R Karagas; Marianne Berwick; Fabrizio Veglia; Paolo Vineis; Giuseppe Matullo
Journal:  Am J Epidemiol       Date:  2006-05-17       Impact factor: 4.897

5.  XRCC3 Thr241Met polymorphism and breast cancer risk: a meta-analysis.

Authors:  Konstantinos P Economopoulos; Theodoros N Sergentanis
Journal:  Breast Cancer Res Treat       Date:  2009-09-30       Impact factor: 4.872

6.  XRCC1 genetic polymorphism Arg399Gln and prostate cancer risk: a meta-analysis.

Authors:  Jian Geng; Qun Zhang; Chuandong Zhu; Jinghua Wang; Longbang Chen
Journal:  Urology       Date:  2009-05-09       Impact factor: 2.649

7.  [Association of the Thr241Met polymorphism of DNA repair gene XRCC3 with genetic susceptibility to AFB1-related hepatocellular carcinoma in Guangxi population].

Authors:  Xi-dai Long; Yun Ma; Zhuo-lin Deng; Yong-zhi Huang; Ni-bo Wei
Journal:  Zhonghua Yi Xue Yi Chuan Xue Za Zhi       Date:  2008-06

8.  The polymorphism of XRCC3 codon 241 and AFB1-related hepatocellular carcinoma in Guangxi population, China.

Authors:  Xi Dai Long; Yun Ma; De Ying Qu; Yun Guang Liu; Zhao Quan Huang; Yong Zhi Huang; Zhong Hui Lin; Ni Bo Wei; Shu Chun Zhou
Journal:  Ann Epidemiol       Date:  2008-05-27       Impact factor: 3.797

9.  Polymorphism of XRCC1 and the frequency of mutation in codon 249 of the p53 gene in hepatocellular carcinoma among Guangxi population, China.

Authors:  Xi Dai Long; Yun Ma; Hong Dong Huang; Jin Guang Yao; De Ying Qu; Yun Long Lu
Journal:  Mol Carcinog       Date:  2008-04       Impact factor: 4.784

10.  High prevalence of mutations at codon 249 of the p53 gene in hepatocellular carcinomas from Senegal.

Authors:  P Coursaget; N Depril; M Chabaud; R Nandi; V Mayelo; P LeCann; B Yvonnet
Journal:  Br J Cancer       Date:  1993-06       Impact factor: 7.640

View more
  11 in total

Review 1.  Host nucleotide polymorphism in hepatitis B virus-associated hepatocellular carcinoma.

Authors:  Shilu Mathew; Hany Abdel-Hafiz; Abbas Raza; Kaneez Fatima; Ishtiaq Qadri
Journal:  World J Hepatol       Date:  2016-04-08

Review 2.  Mode of action-based risk assessment of genotoxic carcinogens.

Authors:  Andrea Hartwig; Michael Arand; Bernd Epe; Sabine Guth; Gunnar Jahnke; Alfonso Lampen; Hans-Jörg Martus; Bernhard Monien; Ivonne M C M Rietjens; Simone Schmitz-Spanke; Gerlinde Schriever-Schwemmer; Pablo Steinberg; Gerhard Eisenbrand
Journal:  Arch Toxicol       Date:  2020-06-15       Impact factor: 5.153

3.  Environmental risk factors for liver cancer and nonalcoholic fatty liver disease.

Authors:  Trang VoPham
Journal:  Curr Epidemiol Rep       Date:  2019-02-06

Review 4.  Association between XPD Lys751Gln and Asp312Asn polymorphisms and hepatocellular carcinoma risk: a systematic review and meta-analysis.

Authors:  Qiliu Peng; Shan Li; Xianjun Lao; Zhiping Chen; Ruolin Li; Xue Qin
Journal:  Medicine (Baltimore)       Date:  2014-12       Impact factor: 1.889

5.  Genetic biomarkers for hepatocellular cancer risk in a caucasian population.

Authors:  Elena De Mattia; Erika Cecchin; Jerry Polesel; Alessia Bignucolo; Rossana Roncato; Francesco Lupo; Marina Crovatto; Angela Buonadonna; Claudio Tiribelli; Giuseppe Toffoli
Journal:  World J Gastroenterol       Date:  2017-09-28       Impact factor: 5.742

6.  IL-10 and PRKDC polymorphisms are associated with glioma patient survival.

Authors:  Mingjun Hu; Jieli Du; Lihong Cui; Tingqin Huang; Xiaoye Guo; Yonglin Zhao; Xudong Ma; Tianbo Jin; Gang Li; Jinning Song
Journal:  Oncotarget       Date:  2016-12-06

7.  The association of six non-synonymous variants in three DNA repair genes with hepatocellular carcinoma risk: a meta-analysis.

Authors:  Yan-Hui Shi; Bin Wang; Bai-Ping Xu; Dan-Na Jiang; Dong-Mei Zhao; Man-Ru Ji; Li Zhou; Xue Li; Chang-Zhu Lu
Journal:  J Cell Mol Med       Date:  2016-06-16       Impact factor: 5.310

8.  Associations between three XRCC1 polymorphisms and hepatocellular carcinoma risk: A meta-analysis of case-control studies.

Authors:  Yao Xiong; Qian Zhang; Jiaxiang Ye; Shan Pan; Lianying Ge
Journal:  PLoS One       Date:  2018-11-08       Impact factor: 3.240

9.  Single Nucleotide Polymorphisms of CBX4 and CBX7 Decrease the Risk of Hepatocellular Carcinoma.

Authors:  Chao Tan; Chunhua Bei; Xiaonian Zhu; Ying Zhang; Linyuan Qin; Shengkui Tan
Journal:  Biomed Res Int       Date:  2019-05-09       Impact factor: 3.411

10.  Prognostic significance of XRCC4 expression in hepatocellular carcinoma.

Authors:  Jun Lu; Xing-Zhizi Wang; Tian-Qi Zhang; Xiao-Ying Huang; Jin-Guang Yao; Chao Wang; Zhong-Hong Wei; Yun Ma; Xue-Min Wu; Chun-Ying Luo; Qiang Xia; Xi-Dai Long
Journal:  Oncotarget       Date:  2017-09-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.